Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8981-8990 Newer>

Pharmaceutical Executive November 1, 2014 Casey McDonald	Advocacy Beat: Progress in Global Access to TB Drugs Treatment Action Group reaches a milestone in improving access to much-needed treatments for tuberculosis.
Pharmaceutical Executive November 1, 2014	EMA -- a Pioneer Permanently At Bay Agency's plan for reporting clinical trial data has sparked strong reactions from health campaigners, industry, and patients.
Chemistry World November 3, 2014 Phillip Broadwith	Chinese buyer resurrects US Boehringer plant Chinese company UniTao has agreed to buy a Boehringer Ingelheim manufacturing site in Petersburg, US, which was scheduled to be closed by the end of the year with the loss of 240 jobs.
Chemistry World November 3, 2014 John Mann	In retrospect: from the pill to the pen One glaring Nobel Prize omission from the pantheon of life-changing drugs is the contraceptive pill. As one of the probable prize recipients, Carl Djerassi is, I believe, justly bitter about this oversight.
CRM November 2014 Maria Minsker	Stryker Takes Brochures into the Digital Age with Adobe's Publishing Suite Adobe DPS cuts production time and cost for the medical device company.
HBS Working Knowledge October 31, 2014 Gautam Mukunda	Ebola's Call To Arms About Disaster Preparedness US health care has just received a critical wake-up call. Risk management tools used to handle normal disruptions are completely inadequate to quell a major catastrophe.
Registered Rep. October 10, 2014 Mark Miller	Healthcare Inflation is on the Mend Tame healthcare inflation is good news for your retired clients.
Chemistry World October 29, 2014 Phillip Broadwith	Judge slashes fines in drug safety case A US judge has once again overturned a jury's decision to extract massive damages from pharmaceutical firms Takeda and Eli Lilly in a case concerning diabetes drug Actos (pioglitazone).
Chemistry World October 29, 2014 Phillip Broadwith	CHF3bn redevelopment for Roche's Basel site Swiss pharma major Roche plans to spend CHF3 billion ( 2 billion pounds) over the next 10 years on redeveloping its headquarters in Basel.
Chemistry World October 28, 2014 Phillip Broadwith	Amgen stacks up additional job cuts US biotech heavyweight Amgen is to cut an extra 600 -- 1100 jobs by the end of 2015, on top of the 2900 the company earmarked for the chop in August.
<Older 8981-8990 Newer> Return to current articles.